Growth Metrics

Lexicon Pharmaceuticals (LXRX) Total Debt (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -8.00%
Dec 31, 2025 -4.42%
Sep 30, 2025 0.70%
Jun 30, 2025 -44.28%
Mar 31, 2025 0.40%
Dec 31, 2024 0.40%
Sep 30, 2024 0.40%
Jun 30, 2024 -0.40%
Mar 31, 2024 0.39%
Dec 31, 2023 0.24%
Sep 30, 2023 0.50%
Jun 30, 2023 102.22%
Mar 31, 2023 0.55%
Dec 31, 2022 104.25%
Sep 30, 2022 0.65%
Jun 30, 2022 0.66%
Sep 30, 2021 0.15%
Jun 30, 2021 0.13%
Mar 31, 2021 0.12%
Dec 31, 2020 -42.69%
Sep 30, 2020 -91.72%
Jun 30, 2020 0.02%
Mar 31, 2020 0.02%
Dec 31, 2019 0.02%
Sep 30, 2019 0.02%
Jun 30, 2019 0.02%
Mar 31, 2019 0.01%
Dec 31, 2018 0.02%
Sep 30, 2018 -0.06%
Jun 30, 2018 -0.12%
Mar 31, 2018 -0.11%
Dec 31, 2017 145.31%
Sep 30, 2017 -0.39%
Jun 30, 2017 -0.48%
Mar 31, 2017 -0.42%
Dec 31, 2016 -0.38%
Sep 30, 2016 -0.36%
Jun 30, 2016 -0.36%
Mar 31, 2016 -0.36%
Dec 31, 2015 -3.15%
Sep 30, 2015 -0.44%
Jun 30, 2015 -0.43%
Mar 31, 2015 -0.42%
Dec 31, 2014 422.43%
Sep 30, 2014 -2.04%
Jun 30, 2014 -1.95%
Mar 31, 2014 -1.92%
Dec 31, 2013 -1.83%
Sep 30, 2013 -1.74%
Jun 30, 2013 -1.67%
Mar 31, 2013 -1.65%
Dec 31, 2012 -1.57%
Sep 30, 2012 -1.50%
Jun 30, 2012 -1.44%
Mar 31, 2012 -1.42%
Dec 31, 2011 -1.37%
Sep 30, 2011 -1.29%